Drugs.com New Drug ApplicationsOriginal article
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
NDA FilingapprovedVaregacestatPositive
AI Analysis
Summary
Immunome announced FDA acceptance of a New Drug Application for Varegacestat for treating adults with desmoid tumors. The acceptance represents a significant milestone in the regulatory pathway for this targeted cancer therapy.
Outcome Details
FDA acceptance of New Drug Application
Importance:7/10
Sentiment:
0.85
FDA AcceptanceNDAVaregacestatDesmoid TumorsOncology
Related Companies
Read the original article
Published by Drugs.com New Drug Applications on July 8, 2026 12:07 AM